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Abstract 27 
Zinc (Zn) plays an important role in maintaining the anti-oxidant status within the heart and 28 
helps to counter the acute redox stress that occurs during myocardial ischaemia and 29 
reperfusion.  Individuals with low zinc (Zn) levels are at greater risk of developing an acute 30 
myocardial infarction, however the impact of this on the extent of myocardial injury is 31 
unknown.  The present study aimed to compare the effects of dietary zinc depletion with in 32 
vitro removal of Zn (TPEN) on the outcome of acute myocardial infarction and vascular 33 
function.  Male Sprague-Dawley rats were fed either a zinc adequate (ZA; 35mg Zn/kg diet) 34 
or zinc deficient (ZD; <1mg Zn/kg diet) diet for 2 weeks prior to heart isolation.  Perfused 35 
hearts were subjected to a 30min ischaemia/2-hour reperfusion (I/R) protocol, during which 36 
time ventricular arrhythmias were recorded and after which infarct size was measured, along 37 
with markers of anti-oxidant status. In separate experiments hearts were challenged with the 38 
Zn chelator TPEN (10µM) prior to ischaemia onset.  Both dietary and TPEN-induced Zn 39 
depletion significantly extended infarct size; dietary Zn depletion was associated with 40 
reduced total cardiac glutathione (GSH) levels, while TPEN decreased  cardiac SOD-1 levels. 41 
TPEN, but not dietary Zn depletion also suppressed ventricular arrhythmias and depressed 42 
vascular responses to nitric oxide NO.  These findings demonstrate that both modes of zinc 43 
depletion worsen the outcome from I/R but through different mechanisms.  Dietary Zn 44 
deficiency, resulting in reduced cardiac GSH, is the most appropriate model for determining 45 
the role of endogenous Zn in I/R injury. 46 
47 
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Introduction 48 
Zinc (Zn) is the second most widely distributed trace element in the body after iron(1)  and the 49 
most abundant intracellular trace element(2). The storage capacity for Zn is low, and therefore 50 
healthy Zn levels are maintained through dietary intake, with around 2-3 mg Zn per day being 51 
required.  However, the prevalence of nutritional Zn deficiency is estimated to be high, and 52 
current estimates suggest that over 2 billion people in the developing world have insufficient 53 
dietary Zn intake(3)..  Moreover, in industrialized countries, elderly people represent a high-54 
risk group as it is known that Zn intake decreases with age, with only ~40% of individuals 55 
aged 71 years or older having an adequate Zn intake(4).  56 
Zn is important in cardiovascular physiology as it acts as an indirect antioxidant, serves to 57 
stabilise membrane structure and regulates metallothionein (MT) levels (reviewed in(5)). The 58 
antioxidant role of Zn is achieved through the requirement of Zn for superoxide dismutase 1 59 
(SOD1) activity, its protection of thiols and its ability to inhibit the Fenton reaction  (which 60 
converts H2O2 to hydroxyl radicals) by competing with iron
(5). Zn is also a physiological 61 
suppressor of apoptosis(6).  Given this essential role in maintaining cellular homeostasis, 62 
disruptions in cellular Zn levels (or alterations in intracellular signalling events involving Zn) 63 
could result in a loss of antioxidant capacity of tissues and may induce, or at least facilitate, 64 
the induction of apoptotic cell death. Consequently, disruption of Zn homeostasis is likely to 65 
play an important role in cardiovascular diseases.  66 
Zn plays a protective role in the four key events that perpetuate myocardial injury following 67 
acute myocardial ischaemia and reperfusion (IR injury); studies have shown that cardiac Zn 68 
counters the acute redox stress that occurs in cardiomyocytes upon reperfusion, inhibits 69 
inflammatory processes that contribute to delayed injury, contributes positively to tissue 70 
healing and assists in maintaining cardiac stem cells involved in tissue repair (reviewed in(7)).   71 
Cardiac and plasma Zn levels are severely depleted in patients post-myocardial infarction, the 72 
extent of depletion correlating with MI outcome(8) and with the levels of enzyme markers 73 
(LDH and CK) of the extent of myocardial injury and the severity of arrhythmia(9), leading to 74 
the proposal that Zn supplementation given at the time of reperfusion may represent a 75 
cardioprotective approach.  Indeed, studies have shown that administration of Zn pyrithione 76 
at the time of reperfusion in isolated hearts can ameliorate reperfusion-induced injury via the 77 
reperfusion injury salvage kinase (RISK) pathway(10), improve post-reperfusion contractile 78 
recovery and reduce reperfusion-induced ventricular fibrillation(11) and, in hyperlipidaemic 79 
hearts, restore the infarct reducing effect of preconditioning(12), while chronic Zn 80 
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supplementation prior to I/R reduces infarct size and increases cardiac glutathione (GSH) 81 
content (13). Conversely, studies looking at acute Zn depletion, using the zinc chelator TPEN 82 
(N,N,N′,N′-tetrakis(2-pyridinylmethyl)-1,2-ethanediamine), demonstrate a worsening of 83 
infarct size (reviewed in(7)) but reduced arrhythmia severity(14,15). However, it is debateable 84 
how closely these experimental conditions mimic the conditions imposed by dietary Zn 85 
deficiency within the heart.  Considering the prevalence of sub-optimal Zn intake in various 86 
populations, and the potentially detrimental impact this may have on the extent of cardiac 87 
injury sustained during an acute myocardial infarction, it is surprising that there is in fact a 88 
paucity of data on this topic. Beyond two experimental dietary Zn depletion studies that show 89 
increased cardiac lipid peroxide levels (but no impact on in infarct size) following sustained 90 
coronary occlusion without reperfusion(16), and a worsening of post-reperfusion recovery of 91 
contractile dysfunction associated with alterations in cardiac tissue anti-oxidant enzymes(17), 92 
very little is known.   93 
In the vasculature, in vivo Zn deficiency is associated with an increased risk of atherogenesis 94 
(reviewed in(18,19)) due to a heightened pro-inflammatory status(20), and experimental studies 95 
have shown that Zn deficiency during foetal development(21) and growth(22) in rats induces 96 
changes in endothelial function that may contribute to the programming for the development 97 
of the hypertension observed in these animals. Dietary Zn deficiency also increases apoptosis 98 
in large arteries through a mechanism involving oxidative stress-induced induction of pro-99 
apoptotic proteins(23), while in vitro studies show that cellular zinc depletion results in a 100 
reduction in endothelial cell barrier function(24) and an increase in vascular smooth muscle 101 
cell proliferation(25). However, to date very little evidence exists as to what functional 102 
consequences these changes have on vascular contraction and relaxation. 103 
The aim of the current study, therefore, was to explore the impact and underlying 104 
mechanisms of dietary Zn deficiency on the outcome (myocardial infarct size and incidence 105 
of arrhythmias) of an acute I/R insult, and on vascular function, in comparison with acute 106 
TPEN-induced Zn deficiency. 107 
 108 
Methods 109 
Animals 110 
Male Sprague-Dawley rats (200-250g), were purchased from Harlan UK and housed in the 111 
University of Aberdeen Medical Research Facility. All animals were maintained at a 112 
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temperature of 21±2°C and humidity of 45±10%, with a 12-hour light/dark cycle and brought 113 
to the Biological Services Unit at the Robert Gordon University on a weekly basis and 114 
allowed to acclimatize before commencing the experimental protocol. All animals, except for 115 
those receiving a zinc deficient (ZD) diet and their pair-fed (PF) counterparts, were housed 116 
using standard caging and allowed free access to both food and tap water. Due to the 117 
requirement to accurately assess food intakes in the ZD and PF rats these animals were single 118 
housed in zinc-free cages with grid flooring; any discomfort caused by the grid flooring was 119 
minimised by the inclusion of zinc-free nesting tunnels/inserts in the cage. These animals 120 
were also housed on a reverse 12h light/dark cycle to allow for twice daily feeding and 121 
measurement of food intake. All studies were performed under an appropriate Project License 122 
authorized under the UK Animals (Scientific Procedures) Act 1986. All in vivo work is 123 
reported in accordance with the ARRIVE guidelines(26). Group sizes were determined based 124 
upon power calculations performed on previous studies using isolated perfused hearts.  125 
Animals were allocated to dietary intervention groups based upon body weight so that pair-126 
fed and zinc deficient animals were of a similar weight at the start of the intervention period.  127 
For the in vitro zinc depletion study, hearts were randomly assigned to control or TPEN 128 
groups. 129 
 130 
Dietary intervention study 131 
To determine the effects of acute zinc deficiency on the outcome of ischaemia/reperfusion 132 
and vascular function, rats (10 per group) were randomly allocated to a 14 day dietary 133 
intervention period of either a zinc-adequate (ZA) diet (35 mg Zn/kg diet) fed ad libitum or a 134 
ZD (<1 mg Zn/kg diet) diet provided twice daily to allow for measurement of food intake.  135 
Both diets have been described elsewhere(27) and were essentially based on the AIN-76A 136 
recommendations.  Since the consumption of a Zn deficient diet results in cyclical feeding 137 
behaviour and reduced weight gain, a further group of 10 rats was included as pair-fed (PF) 138 
controls to determine the impact of reduced weight gain, as opposed to Zn deficiency, on any 139 
of the end-points.  These rats were each weight matched to a ZD rat and fed the same 140 
quantity of ZA food consumed by the Zn-deficient rat the previous day, and body weights of 141 
all rats were monitored daily.  The study parameters and humane end-points were set such 142 
that, if a ZD rat failed to consume any food on any one day, the PF rat would be provided 143 
with a specified quantity of food, and if the body weight of any ZD or PF animal varied by 144 
more than 30% from ZA controls fed ad libitum it would be euthanised by a Schedule 1 145 
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method.  To mitigate against this the duration of dietary Zn restriction and pair feeding was 146 
restricted to 14 days and therefore neither intervention was required during the study. At the 147 
end of the dietary intervention period the rats were euthanised as described below for the 148 
isolated heart experiments. Prior to heart removal blood was withdrawn by cardiac puncture 149 
for biochemical measurements, and tissues (liver, white adipose tissue) removed and 150 
weighed. 151 
 152 
Coronary artery occlusion/reperfusion in the isolated heart 153 
Rats were anaesthetised with pentobarbital sodium salt (100 mg kg-1 i.p; Sigma Aldrich, 154 
Poole, Dorset, UK) and the heart rapidly removed and arrested in ice cold Kreb’s Henseleit 155 
buffer (KHB; 119mM NaCl, 4.7mM KCl, 1.18mM KH2PO4, 2.41mM MgSO4, 25mM 156 
NaHCO3, 2.52mM CaCl2 and 10.88mM Glucose; pH7.4). After placement of a ligature (6-0 157 
silk suture (W812), Ethicon, Edinburgh) around the left coronary artery, the aorta was 158 
cannulated for retrograde perfusion on a Langendorff apparatus (AD Instruments). Hearts 159 
were perfused with KHB at 37oC at a rate of 12ml/min and allowed to stabilize for 15 160 
minutes prior to drug administration and subsequent coronary occlusion. The coronary artery 161 
was occluded (CAO) by tightening the ligature to induce regional ischemia for 30 minutes 162 
after which the ligature was loosened and the myocardium reperfused for 2 hours. A surface 163 
electrocardiogram (ECG) was recorded via electrodes placed on the right atrium and left 164 
ventricle and coronary perfusion pressure (CPP) recorded via a pressure transducer (MLT844 165 
physiological pressure transducer; AD Instruments) connected to the mounting head of the 166 
Langendorff apparatus. Ventricular arrhythmias that occurred during the ischaemic period 167 
were analysed according to the Lambeth Conventions(28). Heart rate (HR; calculated from the 168 
ECG), ECG, and CPP were all monitored continuously throughout the experimental period 169 
using a Power Lab data acquisition system via an Animal Bio Amplifier and Bridge 170 
Amplifier, respectively, and data subsequently analysed using Chart Software (all equipment 171 
and software from AD Instruments). Any hearts which developed spontaneous arrhythmias 172 
prior to CAO were excluded from the study. Hearts from rats included in the dietary 173 
intervention study were used to determine the effect of acute dietary Zn depletion on the 174 
outcome or I/R. To determine the impact of acute in vitro Zn depletion, either vehicle (0.01% 175 
DMSO; n=10) or TPEN (10µM; concentration chosen based on previously published work in 176 
isolated heart studies(14,29)) was infused (at a rate of 100µL/min) into isolated hearts via the 177 
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aortic cannula starting 5 minutes prior to ischaemia and terminating immediately before 178 
CAO. 179 
 180 
Histological measurement of infarct size 181 
Following completion of the ischaemia/reperfusion protocol, the ligature around the coronary 182 
artery was retied and Evans blue dye (2ml; 0.5% w/v) perfused through the heart to delineate 183 
area at risk. Hearts were then removed and stored at –20oC prior to infarct size determination. 184 
Frozen hearts were sliced into 2-3mm slices from the apex to the base and allowed to defrost 185 
at room temperature. Myocardial tissue slices were then incubated in 1% 186 
triphenyltetrazonium chloride (TTC; Sigma Aldrich, UK) in phosphate buffered saline for 15 187 
minutes at 37oC to determine infarct size. Sections were then fixed in 10% buffered formal 188 
saline for 1 hour and imaged using an EOS 1100D digital SLR camera (Canon Inc., Tokyo, 189 
Japan) attached to a Leica S4E stereomicroscope (Leica Microsystems Ltd., Milton Keynes, 190 
UK). Left ventricular area, area at risk, and infarct size were determined using computerised 191 
planimetry (ImageJ software, National Institute of Health (NIH), Rockville Pike Bethesda, 192 
MD). Area at risk was expressed as a percentage of total left ventricular area, and infarct size 193 
was expressed as a percentage of area at risk. 194 
 195 
Isometric myography 196 
Once hearts were mounted on the Langendorff apparatus and in the stabilisation period, the 197 
mesenteric arterial arcade was excised and placed in ice cold KHB. Third order mesenteric 198 
arteries were then dissected out, cleaned of perivascular fat, and stored in KHB overnight at 199 
4oC. Vascular function was then assessed in isolated mesenteric arteries mounted onto a two-200 
channel wire myograph (Model 510A, Danish Myo Technology (DMT), Denmark) 201 
containing oxygenated (95% O2 & 5% CO2) KHB at 37
oC. Vessels were normalised to 202 
achieve a transmural pressure of 100mmHg using the DMT Normalisation software. 203 
Isometric tension was recorded and displayed using a PowerLab and Chart Software (both 204 
AD Instruments). The viability of the smooth muscle was tested via the addition of an 80mM 205 
KCl solution. Following KHB washes, a cumulative concentration response was carried out 206 
with the thromboxane mimetic, U46619 (9,11-Dideoxy-11α,9α-epoxymethanoprostaglandin 207 
F2α; Tocris Bioscience, UK). Vessels were then precontracted with a submaximal 208 
concentration (EC80) of U46619 and cumulative concentration responses carried out with 209 
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either the endothelium-dependent vasodilator, metacholine (MCh) or the endothelium-210 
independent vasodilator, sodium nitroprusside (SNP). Vessels from the dietary intervention 211 
groups were used to determine the impact of in vivo zinc depletion on vascular function.  To 212 
determine the effect of acute in vitro Zn deficiency on vascular function either (0.01% 213 
DMSO), TPEN (10µM), or DPTA (10µM; extracellular zinc chelator,) was added to the 214 
myograph bath prior to performing cumulative concentration responses to either MCh or 215 
SNP.  216 
 217 
Myocardial Cu/Zn-SOD activity 218 
Cu/Zn-SOD activity was measured in cardiac tissue samples (representing both ischaemic 219 
and non-ischaemic tissue) from all experimental groups using a Superoxide Dismutase Assay 220 
Kit (catalogue number: 706002; Cayman Chemical). Briefly, cardiac tissue was homogenised 221 
in ice cold 20mM HEPES buffer (pH 7.2) containing 1mM EGTA, 210mM mannitol, and 222 
70mM sucrose. The resulting homogenate was then subjected to multiple centrifugation steps 223 
to separate mitochondrial and cytosolic SOD, the latter of which was retained for subsequent 224 
analysis. Following protein quantification, protein concentrations were normalised to 225 
0.5mg/ml in all samples and Cu/Zn-SOD activity measured via the kit as per the 226 
manufacturer’s instructions. 227 
 228 
Myocardial glutathione (GSH) content 229 
Total GSH content was measured in cardiac tissue using a Glutathione Assay Kit (catalogue 230 
number: 703002; Cayman Chemical). Briefly, cardiac tissue (representing both ischaemic and 231 
non-ischaemic tissue) was homogenised in ice cold MES buffer (pH 6.0) containing 200mM 232 
2-(N-morpholino) ethanesulphonic acid, 50mM phosphate, and 1mM EDTA. The resulting 233 
homogenate was then centrifuged at 10,000g for 15 minutes at 4oC, the supernatant removed 234 
and subsequently deproteinated via the addition of MPA reagent (1.25M metaphosphoric 235 
acid). Samples containing MPA reagent were then centrifuged at 3,000g for 2 minutes at 236 
room temperature, the supernatant removed and TEAM reagent (4M triethanolamine) added 237 
before assaying for GSH content as per the manufacturer’s instructions. 238 
 239 
 240 
 241 
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Myocardial caspase-3 activity 242 
Caspase-3 activity in heart tissue was determined by measuring conversion of the caspase-3 243 
substrate N-Acetyl-Asp-Glu-Val-Asp p-nitroanilide (Ac-DEVD-Pna) to p-nitroaniline.  244 
Briefly, tissue samples (representing both ischaemic and non-ischaemic tissue) were 245 
homogenised in ice cold HEPES buffer (25mM; pH 7.4) containing 5 mM EDTA, 2 mM 246 
DTT and 0.1% CHAPS and centrifuged at 20,000g for 30 minutes at 4⁰C).  The supernatant 247 
(5μl) was then incubated with 85μl HEPES buffer (50mM; pH 7.4, containing 1.0mM EDTA, 248 
10mM DTT, 0.1% Chaps, 100mM NaCl and 10% glycerol) and 10μl Ac-DEVD-Pna 249 
(200μM) at 37⁰C for 24 hours; the concentration of the  product (p-nitroaniline) was read at 250 
405nm. 251 
 252 
Myocardial and plasma zinc levels 253 
Cardiac tissue zinc levels were measured using a Zinc Assay Kit (catalogue number: 254 
MAK032; Sigma Aldrich UK). Samples were prepared as for the Cu/Zn-SOD activity assay 255 
and protein concentrations were normalised to 0.5mg/ml. Zn was measured via the kit as per 256 
the manufacturer’s instructions, with the omission of the deproteination step to measure both 257 
free and protein-bound Zn. For determination of circulating trace metal levels plasma 258 
samples were analysed using a Unicam Solaar 969 atomic absorption spectrophotometer as 259 
described previously(30) and lactate dehydrogenase and creatine kinase levels were 260 
determined using a Konelab clinical analyser. 261 
 262 
Statistical analyses 263 
All data are expressed as mean ± s.e.m. and significance determined as P<0.05. For the acute 264 
zinc deficiency study, the ZD groups were compared to the PF group as the appropriate 265 
control to eliminate any impact of reduced energy intake on the end points.  The impact of 266 
reduced energy intake on end points was determined by comparing the PF group with the ZA 267 
group. A two tailed Student’s T-test was used to compare baseline CPP/HR values in the 268 
vehicle and TPEN treated hearts and compare the effect of TPEN on both CPP and HR. A 269 
one-way analysis of variance (ANOVA) & Dunnett’s post-hoc test was used to compare pre-270 
occlusion and post-occlusion CPP/HR values within experimental groups and a repeated 271 
measures ANOVA & Bonferroni post-hoc test used to compare post-occlusion CPP/HR 272 
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between the vehicle and TPEN groups. For the acute zinc deficiency study, a one-way 273 
ANOVA & Dunnett’s post-hoc test was used to compare baseline CPP/HR values in the ZA, 274 
PF and ZD experimental groups and the pre-occlusion and post-occlusion CPP/HR values 275 
within the same experimental groups. A two-way ANOVA & Bonferroni post-hoc test used 276 
to compare post-occlusion CPP/HR values between the ZA, PF and ZD experimental groups. 277 
In both experimental studies, ventricular arrhythmias were determined from the ECG trace 278 
and classified according to the Lambeth Conventions (II)(28). The effect of TPEN on the 279 
number of each type of ventricular premature beat (VPB) i.e. singles, salvos, ventricular 280 
tachycardia (VT) and total VPB count was analysed using a two-way ANOVA & Bonferroni 281 
post-hoc test. The effect of TPEN on the incidence of VT, reversible ventricular fibrillation 282 
(rVF), and irreversible (irrVF)/mortality was analysed using a Fisher’s exact test. In the acute 283 
zinc deficiency study, the impact of the dietary interventions on the number of VPBs and 284 
incidences of VT, rVF and mortality were compared between groups using a two-way 285 
ANOVA & Bonferroni post-hoc test and Fisher’s exact test, respectively. Nonlinear 286 
regression (using GraphPad Prism) was used to generate curves for all vascular data, and to 287 
calculate and compare pEC50 values for each group. Concentration responses between groups 288 
were compared via a repeated measures ANOVA and Bonferroni post-hoc test. Emax values 289 
(maximal relaxation as a percentage of induced tone) were compared using either a t-test 290 
(acute zinc deficiency study) or a one-way ANOVA & Dunnett’s post-hoc test (in vivo zinc 291 
deficiency study). Similarly, food intake, BW, HW:BW, area at risk, infarct size, Cu/Zn-SOD 292 
activity, GSH content, caspase-3 activity, and plasma/cardiac zinc levels were all compared 293 
using either a t-test or where appropriate a one-way ANOVA & Dunnett’s post-hoc test. 294 
 295 
Results 296 
Impact of dietary zinc depletion on physiological measures 297 
Consumption of the zinc-deficient diet resulted in characteristic cyclical feeding behaviour 298 
associated with acute zinc depletion in rats in that food consumption reduced by 299 
approximately 50% every 2-3 days; the PF rats were therefore subjected to the same cyclical 300 
feeding (Figure 1a). Consequently, zinc deficiency resulted in a significantly reduced weight 301 
gain over the 14-day period of intervention compared to normal-fed ZA rats (Figure 1b).  PF 302 
rats given a zinc adequate diet also exhibited a reduced weight gain, but to a lesser extent 303 
than the ZD rats.  ZD rats had a higher HW;BW ratio (Figure 1c) and a lower white adipose 304 
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tissue (WAT) to BW ratio (indicative of altered body fat composition; Figure 1d). Plasma 305 
analysis confirmed that circulating zinc levels in the ZD rats were significantly lower than 306 
those in both ZA and PF rats (Figure 1e), while cardiac tissue Zn levels were similar across 307 
all groups (Figure 1f). All other plasma markers (Cu2+, Ca2+, lactate and creatine kinase) were 308 
unchanged (Supplementary Table 1). 309 
 310 
Dietary Zn depletion and the outcome of myocardial ischaemia/reperfusion 311 
Dietary zinc deficiency caused a significant increase in infarct size compared to the extent of 312 
damage seen in hearts from PF rats (Figure 2a; AAR 56±2% and 48±6% respectively); 313 
Infarct sizes in PF and ZA rats (AAR 43±3%) were not significantly different. PF rats 314 
exhibited a marked increase in cardiac caspase-3 activity compared to ZA rats while ZD rats 315 
exhibited similar myocardial caspase-3 activity to ZA rats (Figure 2b). Pair feeding had no 316 
impact on either GSH levels or Cu/Zn-SOD activity, while in ZD rats there was a marked 317 
reduction in GSH levels (Figure 2c) but no change in Cu/Zn-SOD activity (Figure 2d). 318 
Arrhythmia analysis revealed that PF animals exhibited a significantly fewer VPBs occurring 319 
as salvos (2-3 consecutive VPBs) and ventricular tachycardia (VT; 4 or more consecutive 320 
VPBs; Figure 3a), although the incidence of VT and total VF was unaffected (Supplementary 321 
Table 2); the arrhythmia profile in ZD rats was similar to that in PF rats. Baseline coronary 322 
perfusion pressures (Figure 3b) and heart rates (Figure 3c) were the same irrespective of 323 
dietary intervention, and the ischaemia-induced rise in perfusion pressure was similar in all 324 
groups, but only reached statistical significance in the ZD group. 325 
 326 
Dietary Zn depletion and vascular function 327 
Contractile responses to U46619 was unaffected by either pair feeding or zinc deficiency 328 
(Table 1). Similarly, blood vessels from both PF and ZD rats exhibited comparable 329 
endothelium-dependent (MCh; Figure 4a) and independent (SNP; Figure 4b) vasodilator 330 
responses, with no alterations in either Emax or pEC50 (Table 1). 331 
 332 
Acute in vitro Zn depletion and the outcome of myocardial ischaemia/reperfusion 333 
Perfusion with TPEN (10µM) prior to the onset of coronary artery occlusion caused a 334 
significant increase in infarct size compared to control hearts (P<0.05; Figure 5a); area at risk 335 
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was similar in both groups (43±3% vs 45±3% of LV area in control and TPEN-treated hearts, 336 
respectively). Treatment with TPEN did not induce any significant reduction in tissue Zn 337 
levels (Figure 5b).  The induction of I/R itself cause a reduction in both GSH levels (Figure 338 
5c) and Cu/Zn-SOD activity (Figure 5d) when compared to sham hearts, whereas I/R did not 339 
alter caspase-3 activity (Figure 5e). There was no impact of TPEN treatment on GSH content 340 
or caspase-3 activity, however in hearts given TPEN there was a significant reduction in 341 
Cu/Zn-SOD activity compared to control I/R hearts (Figure 5d; P<0.05). TPEN also 342 
markedly reduced the number of ventricular arrhythmias occurring as single VPBs, salvos 343 
and VT (Figure 6a), and significantly reduced the incidence of VT but had no effect on the 344 
development of ventricular fibrillation (VF; Supplementary Table 3). Prior to coronary 345 
occlusion, TPEN induced a rise in CPP (Figure 6b), which was maintained throughout the 346 
period of regional ischaemia (Figure 6c). In contrast, neither the administration of TPEN nor 347 
the induction of regional ischaemia significantly altered heart rate in any of the isolated hearts 348 
(Figure 6d). 349 
 350 
Acute in vitro Zn depletion and vascular function 351 
TPEN (10µM) significantly reduced the contractile response to U46619, which was used to 352 
pre-contract vessel rings to determine vasodilator responses (Table 2). Similarly, TPEN 353 
induced a significant shift to the right of the dose response curves and a reduction in 354 
maximum relaxant responses to both MCh (endothelium-dependent) and SNP (endothelium-355 
independent) (Figure 7a,b & Table 2). In contrast DPTA (extracellular Zn chelator; 10µM) 356 
did not affect either the contractile response to U46619 or the vasodilator responses to MCh 357 
or SNP (Figure 7c,d & Table 2).  358 
 359 
Discussion 360 
The majority of studies determining the value of Zn in cardio- and vasculo-protection have 361 
focused on exogenous Zn supplementation, rather than considering the importance of 362 
endogenous Zn in maintaining a healthy and resilient cardiovascular system. This study 363 
aimed to determine the effects of endogenous Zn depletion, induced by two distinct methods 364 
(in vivo dietary deficiency and in vitro removal of intracellular Zn) to demonstrate the 365 
importance of maintaining adequate Zn levels to protect the heart in the event of an acute 366 
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myocardial infarction and also to determine the most physiologically relevant experimental 367 
model for further study. 368 
 369 
Dietary deficiency vs acute depletion effects on zinc and blood/tissue marker status 370 
Induction of dietary Zn deficiency for 14 days led to a slowed increase in body weight 371 
resulting from the reduced food intake, leading to lower fat accumulation (reduced WAT;BW 372 
ratio) and an increase in heart:BW ratio. In ZD rats, plasma Zn was markedly reduced (by 373 
>50%), while other blood markers that could influence infarct size (Cu2+ and Ca2+, lactate 374 
and CK levels; Supplemental Data Table 1) were unaffected; thus, any difference between the 375 
ZD rats and the ZA/PF rats can be attributed to alterations in plasma Zn status alone.  376 
However, dietary Zn deficiency did not significantly alter cardiac tissue levels of Zn which, 377 
although perhaps surprising, agrees with other studies(16,17). Notwithstanding this, it is worthy 378 
of note that the tissue Zn levels reported here represent protein-bound Zn, as Zn levels were 379 
undetectable in deproteinated samples (lower detection limit of the assay was 0.5nmol per 380 
sample), indicating that there was no detectable free Zn to participate in Zn-dependent 381 
cellular process such as glutathione synthesis (see below).  382 
The mechanism by which cardiac tissue levels of Zn are maintained in the face of dietary 383 
deficiency is not clear but is likely linked to the tight control systems that maintain 384 
intracellular Zn homeostasis.  The homeostatic mechanisms in the cardiomyocyte are as yet 385 
poorly defined(31) but in most cells intracellular Zn concentration is kept within a tight 386 
window by two families of zinc transporters (ZnT and ZIP).  ZnT’s promote efflux from the 387 
cell while ZIP’s increase intracellular zinc by promoting transport into the cytoplasm 388 
(reviewed in(32)).  Additional control is provided by metallothionein(33), which is largely a 389 
mechanism to protect the cell against excessive increases in intracellular Zn.  ZnT2 and 390 
ZnT5, along with most of the ZIP transporters, are known to be expressed in cardiac tissue(34), 391 
and in non-cardiac cells ZnT2 is markedly downregulated in response to Zn deficiency while 392 
ZIP 2 and ZIP 4 are upregulated. If this is also the case in the cardiomyocyte this would result 393 
in reduced Zn efflux alongside increased entry, which could explain the preservation of the 394 
Zn levels in cardiac tissue despite dietary deficiency.   395 
In vitro acute Zn depletion, achieved by treating hearts with TPEN, similarly did not alter 396 
total tissue Zn content. While alterations in zinc transporter activity may similarly explain 397 
preserved cardiac Zn levels in TPEN-treated hearts, we cannot rule out the possibility that the 398 
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effects of TPEN are due to removal of other cations (such as Ca2+).  However, at the 399 
concentrations used in the present study TPEN has a much higher affinity for Zn. 400 
 401 
Zn and I/R injury 402 
While there are substantial data to support the notion that supplementation with exogenous 403 
Zn in the setting of I/R is cardioprotective, relatively little is known about the importance of 404 
endogenous Zn in the development of myocardial injury(5). Endogenous Zn has been reported 405 
to be both cardioprotective, by acting as an intracellular messenger that translates the 406 
signalling process in NO-mediated cardioprotection(35), and detrimental, through activation of 407 
ERK/GSK3β to trigger cardiomyocyte death(36) in I/R. However very few studies have 408 
determined whether depletion of endogenous zinc levels can influence the outcome of I/R.   409 
In this study we have shown that both acute dietary Zn deficiency and acute in vitro Zn 410 
depletion increase infarct size following I/R injury in isolated hearts, which is consistent with 411 
the notion that Zn is cardioprotective. Since endogenous Zn is known to play an important 412 
role in maintaining redox status within tissues(37), we also determined whether Zn deficiency 413 
upset the redox balance in cardiac tissue as a possible mechanism for the increase in tissue 414 
injury.   415 
In the case of dietary Zn deficiency, there was a marked reduction in total myocardial GSH 416 
levels of ZD rats compared to both ZA and PF rats.  This provides a plausible explanation for 417 
the increase in infarct size since GSH is a powerful antioxidant that prevents ROS-induced 418 
tissue injury(38) and reduced GSH levels have been associated with a detrimental effect on 419 
tissue integrity following I/R injury(39). Zn is an important co-factor in GSH synthesis as it 420 
increases the expression of glutamate cysteine ligase (GCL), the enzyme that catalyses GSH 421 
synthesis. Zn deficiency has been shown to reduce GSH levels in other tissues and cells such 422 
as liver(40,41), erythrocytes(42) and brain(43), but to our knowledge this is the first time this 423 
effect has been observed in cardiac tissue. However, while dietary Zn deficiency-induced 424 
GSH deficit has been linked to increased cleavage of GCL(44) resulting from activation of 425 
caspase-3(45), we did not see any increase in caspase-3 activity in hearts from ZD rats. 426 
Interestingly, hearts from PF rats exhibited higher caspase-3 activity, which is surprising 427 
since calorie restriction has been associated with caspase-3 inactivation in the heart(45), albeit 428 
for longer (15-35 weeks) and more severe (30% reduction in food intake) calorie restriction. 429 
Although Zn is similarly an important co-factor for the cytosolic superoxide scavenging 430 
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enzyme Cu/Zn-SOD (SOD-1) which, when applied exogenously to the heart upon 431 
reperfusion, is cardioprotective(46) we did not observe any changes in SOD-1 activity that 432 
could explain the impact of dietary Zn depletion on infarct size. However, this is consistent 433 
with the finding that endogenous SOD-1 deficiency does not influence the extent of 434 
reperfusion injury(47). 435 
The only previous study of dietary Zn deficiency on myocardial injury, performed in rats 436 
subjected to permanent and sustained (48 hour) coronary occlusion, showed that despite a 437 
significant increase in cardiac lipid peroxide levels there was no effect on infarct size(16). 438 
However, because lethal injury as a result of oxidative stress is induced upon reperfusion, and 439 
since Zn deficiency is known to diminish the ability of cells to respond to oxidative stress 440 
(reviewed in(37)), this supports the concept that endogenous zinc is important in moderating 441 
the extent of reperfusion, rather than ischaemic, injury. Indeed, our results with dietary Zn 442 
depletion are supported by findings that contractile recovery post I/R is significantly impaired 443 
in hearts from Zn deficient rats(17).   444 
To correct for any influence of reduced food intake caused by cyclical feeding behaviour 445 
induced by the Zn deficient diet, we included PF animals as controls and found that pair 446 
feeding per se had no significant effect on the extent of I/R injury compared to ZA rats. Short 447 
term (7-14 days) caloric restriction has been associated with a cardioprotective effect in terms 448 
of post I/R recovery of cardiac function(48) and a reduction in infarct size following 449 
permanent coronary occlusion(49). Therefore, since there was no expansion of infarct size in 450 
the PF hearts we can tentatively conclude that the worsening of I/R in the ZD rats is due to 451 
the lack of zinc rather than to reduced food, and therefore energy, intake.  452 
Although in vitro endogenous Zn depletion with TPEN similarly resulted in an increase in 453 
infarct size, unlike dietary deficiency this was associated solely with a reduction in Cu/Zn-454 
SOD activity since glutathione levels were preserved and there was no evidence of caspase-3 455 
activation. Although, as mentioned above, endogenous SOD-1 has been shown to be an 456 
unlikely contributor to post-reperfusion tissue preservation, it is not the only Zn-dependent 457 
isoform of superoxide dismutase. Extracellular SOD (ecSOD; SOD-3), which is concentrated 458 
in the extracellular space between smooth muscle cells and the endothelium of the vascular 459 
wall, plays a critical role in regulating the vascular redox state(50) and evidence suggests that 460 
it is the interstitial levels of SOD-3, rather than SOD-1, that confers protection against I/R 461 
injury(51). Since our assay measures total Cu/Zn-SOD (i.e. SOD-1 and SOD-3) then the 462 
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increase in infarct size is most likely due to an inhibition of SOD-3, rather than SOD-1 463 
activity. 464 
As with dietary Zn deficiency, very few studies have employed TPEN to determine the 465 
effects of acute endogenous Zn depletion on myocardial infarct size. While the expansion of 466 
infarct size in the presence of TPEN is compatible with numerous studies showing that Zn 467 
supplementation is cardioprotective (reviewed in (5)), the only other study to explore the role 468 
of endogenous Zn in infarct size using TPEN showed it to be cardioprotective when applied 469 
throughout reperfusion(36). While this is difficult to reconcile with the present data, it is most 470 
likely explained by differences in experimental protocols (i.e. pre-ischaemia vs post-471 
reperfusion administration), but certainly requires further investigation. 472 
 473 
Zn and ventricular arrhythmias 474 
In contrast to the effects on myocardial infarct size, dietary Zn deficiency did not have any 475 
worsening effect on the severity of ventricular arrhythmias but rather, when compared to ZA 476 
hearts, ZD hearts had a lower total arrhythmia count during the ischaemic period, 477 
predominantly due to a reduction in salvos, although the incidence of the more severe 478 
arrhythmias (VT and VF) were not changed.  However, this effect is most likely explained by 479 
the reduced energy intake, as opposed to Zn depletion, in these animals as hearts from PF rats 480 
similarly exhibited fewer arrhythmias. Indeed, caloric restriction has been shown to induce 481 
bradycardia, prolong QT- and QRS-intervals and to reduce the arrhythmogenic response to 482 
adrenaline through a reduction in β-adrenoceptor density and binding(52). Although we did not 483 
see any difference in baseline heart rates between ZA, ZD and PF hearts, these were 484 
measured in isolated hearts without the influence of sympathetic tone and so any β-485 
adrenoceptor mediated impairment would not be detected. TPEN, on the other hand did exert 486 
a significant anti-arrhythmic effect by reducing total arrhythmia count and the incidence of 487 
VT during ischaemia. It is unlikely that this was related to the reduction in SOD-1/3 activity 488 
since neither superoxide generation nor superoxide scavenging has been associated with a 489 
pro- or anti-arrhythmic effect (respectively) in this model(53). However, other studies 490 
describing the antiarrhythmic effects TPEN have ascribed these to inhibition of nitric oxide 491 
accumulation(14) and activation of the sarcolemmal Na+/Ca2+ exchanger to prevent Ca2+ 492 
overload(15).   493 
 494 
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Vascular effects of Zn depletion 495 
Zn deficiency/depletion is associated with adverse effects on both vascular smooth muscle(23) 496 
and endothelial(24) cells that would be expected to result in abnormalities of blood vessel 497 
function. Indeed, dietary Zn deficiency during foetal development(21) and growth(22) results in 498 
elevated blood pressure, and in adult hypertensive animals Zn deficiency exaggerates the 499 
elevated blood pressure(44), effects that are believed to be a consequence of increased 500 
oxidative stress resulting in endothelial impairment and reduced availability of nitric oxide.  501 
However, in normotensive adult animals subjected to dietary Zn deficiency blood pressure is 502 
unaffected and both endothelial nitric oxide synthase (eNOS) and SOD-1 expression is 503 
normal(55). Although we did not measure arterial blood pressure in our dietary intervention 504 
study, the lack of effect of zinc deficiency on baseline coronary perfusion pressures, which 505 
gives an indication of vascular tone in the coronary resistance bed, and the normal responses 506 
to both and endothelium-dependent (MCh) and independent (SNP) vasodilator in blood 507 
vessels isolated from the ZD rats is consistent with the view that dietary Zn deficiency in 508 
normotensive adult animals does not impair vascular function, despite the pathological 509 
remodelling that has been demonstrated in previous studies(20,23).  510 
While the impact of acute in vitro Zn depletion has been explored at the cellular level, very 511 
little has been done to determine the functional consequence in isolated intact blood vessels.  512 
Here we have shown that, in contrast to dietary intervention, exposure of mesenteric arteries 513 
to TPEN impairs both contractile and relaxant (endothelium-dependent and independent) 514 
responses, while the extra-cellular Zn chelator DPTA does not. Thus, in light of the observed 515 
impact of TPEN on cardiac SOD activity, the most likely cause of the reduced endothelium-516 
dependent responses is the inhibition of SOD-1 (cytosolic isoform), since DPTA would only 517 
remove the zinc that would allow SOD-3 (located within the interstitial spaces) to operate, 518 
whereas TPEN would reduce Zn availability for both SOD-1 and SOD-3.  This would also 519 
explain the reduced response to SNP, which donates a NO moiety that is as susceptible to 520 
degradation by ROS as endogenously produced NO. In relation to the attenuation of the 521 
contractile response seen with TPEN, although as a chelator it has a higher affinity for Zn 522 
than for other metals, it has been shown in other cell types to impair intracellular calcium 523 
release from the sarcoplasmic reticulum(56), albeit at much higher concentrations (50-500µM) 524 
that that used in the current study (10µM).  525 
 526 
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Conclusions 527 
The principal findings from these studies are that both acute dietary Zn deficiency and acute 528 
in vitro Zn depletion worsen the extent of myocardial injury resulting from I/R while 529 
paradoxically protecting against severe ventricular arrhythmias. The mechanisms by which 530 
these effects are achieved, however, appear to differ. Dietary Zn deficiency results in a 531 
reduction in total cardiac GSH content, which predisposes the heart tissue to the widespread 532 
damaging effects of the oxidative stress induced during post-ischaemic reperfusion, while the 533 
predominant system that is affected by in vitro Zn depletion is the limited capacity to 534 
scavenge superoxide. Similarly, while in vitro Zn depletion has a marked effect on the ability 535 
of intact blood vessels to both contract and relax, dietary Zn deficiency does not. Again this 536 
appears to be related to the differing effects of the two interventions on SOD activity.  Taken 537 
together these results have shown that dietary insufficiency of Zn presents a potential risk 538 
factor for a worse outcome following acute myocardial ischaemia, with the associated 539 
increased morbidity and mortality.  Moreover, our findings with TPEN suggest that future 540 
studies into the role of zinc in cardiovascular physiology and pathophysiology should be 541 
carried out using a dietary intervention model, rather than an in vitro simulation of 542 
endogenous Zn depletion, to avoid misleading findings. 543 
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Figure Legends 707 
Figure 1:  Physiological alterations in response to a Zn-deficient diet in rats.  Zn deficiency 708 
(ZD) resulted in a cyclical feeding pattern (A) that resulted in a slowed rate of growth (B).  709 
Pair feeding (PF) of rats a zinc adequate diet also slowed growth, but to a lesser extent.  ZD 710 
also influenced heart (HW; C) and white adipose tissue (WAT;D) to body weight (BW) 711 
ratios.  The impact of the ZD diet compared to PF and zinc adequate (ZA) on cardiac tissue 712 
(E) and plasma (F) Zn levels is also shown.  Values are mean ± s.e.m;  N=10 for panels A-D; 713 
n=4 for panels E&F. *P<0.05 compared to PF control animals. 714 
 715 
Figure 2:  The impact of a ZD diet on myocardial infarct size (A), caspase-3 activity (B), 716 
glutathione (GSH) content (C) and SOD-1 (Cu/Zn SOD) activity (D) in isolated hearts 717 
subjected t 30 min acute regional myocardial ischaemia and 2 h reperfusion. Values are mean 718 
± s.e.m; n=10 per group. *P<0.05 ZD compared to PF controls; #P<0.05 PF compared with 719 
ZA controls. 720 
 721 
Figure 3:  The influence of a ZD diet on arrhythmia count (A), the incidence of ventricular 722 
tachycardia (VT and fibrillation (VF; B) and changes in coronary perfusion pressure (CPP: 723 
C) and hearts rate (HR; D) prior to and during the ischaemia/reperfusion protocol.  Values are 724 
mean ± s.e.m; n=10 per group. #P<0.05 PF compared with ZA controls; *P<0.05 compared 725 
with pre-ischaemic ZD values. 726 
  727 
Figure 4:  Responses of mesenteric arteries from ZA, PF and ZD rats, pre-contracted with 728 
U46618 (EC80), to the endothelium-dependent vasodilator methacholine (MCh; A) and the 729 
directly acting vasodilator sodium nitroprusside (SNP; B). Values are mean ± s.e.m; n=10 per 730 
group. 731 
 732 
Figure 5:  The effect of the Zn chelator TPEN (10μM) on myocardial infarct size (A), 733 
cardiac tissue Zn content (B), glutathione (GSH) content (C) and SOD-1 (Cu/Zn SOD) 734 
activity (D) and caspase-3 activity (B),  in isolated hearts subjected to 30 min acute regional 735 
myocardial ischaemia and 2 h reperfusion. Values are mean ± s.e.m; n=10 per group. 736 
*P<0.05 compared to vehicle controls; #P<0.05 compared with sham controls.  737 
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Figure 6:  The influence of TPEN (10μM) on arrhythmia count (A), the incidence of 738 
ventricular tachycardia (VT and fibrillation (VF; B) and changes in coronary perfusion 739 
pressure (CPP: C) and heart rate (HR; D) prior to and during the ischaemia/reperfusion 740 
protocol.  Values are mean ± s.e.m; n=10 per group. *P<0.05 vs vehicle control. 741 
 742 
Figure 7:  The effects of TPEN (10μM; A & B) and the extracellular Zn chelator DPTA 743 
(10μM; C & D) on responses of mesenteric arteries to the endothelium-dependent vasodilator 744 
methacholine (MCh) and the directly acting vasodilator sodium nitroprusside (SNP). Values 745 
are mean ± s.e.m; n=10 per group. P<0.05 compared to control. 746 
 747 
Supplementary Table 1: 748 
The effect of a ZD diet, compared to a ZA  and PF diet on plasma concentrations of Cu2+ and 749 
Ca2+, and on plasma lactate and creatine kinase.  Values are mean ± s.e.m; n=10 per group. 750 
 751 
Supplementary Table 2: 752 
The incidences of ventricular tachycardia (VT) and reversible (Rev VF) and irreversible 753 
(Irrev VF) ventricular fibrillation in rats fed either a ZA or a ZD diet, and in PF controls.  754 
Values are expressed as the number of animals from each group, with percentage incidences 755 
in parentheses). 756 
 757 
Supplementary Table 3: 758 
The incidences of ventricular tachycardia (VT) and reversible (Rev VF) and irreversible 759 
(Irrev VF) ventricular fibrillation in rat hearts treated with either TPEN (10µM) or vehicle 760 
prior to the onset of acute myocardial ischaemia.  Values are expressed as the number of 761 
animals from each group, with percentage incidences in parentheses). 762 
 763 
764 
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TABLE 1:  Emax and EC50 values for responses to vasoactive agents in mesenteric arteries 765 
from ZA, ZD and PF rats. Values are mean ± s.e.m; n=10 per group. 766 
 767 
 768 
TABLE 2:  Emax and EC50 values for responses to vasoactive agents in mesenteric arteries 769 
from ZA, ZD and PF rats. Values are mean ± s.e.m; n=10 per group. 770 
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